ES2883147T3 - Composiciones y métodos para el tratamiento de heridas crónicas - Google Patents
Composiciones y métodos para el tratamiento de heridas crónicas Download PDFInfo
- Publication number
- ES2883147T3 ES2883147T3 ES17750709T ES17750709T ES2883147T3 ES 2883147 T3 ES2883147 T3 ES 2883147T3 ES 17750709 T ES17750709 T ES 17750709T ES 17750709 T ES17750709 T ES 17750709T ES 2883147 T3 ES2883147 T3 ES 2883147T3
- Authority
- ES
- Spain
- Prior art keywords
- wound
- healing
- pharmaceutical composition
- wounds
- dressing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/60—Liquid-swellable gel-forming materials, e.g. super-absorbents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/0066—Medicaments; Biocides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/008—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
- A61L2300/406—Antibiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
- A61L2300/414—Growth factors
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Materials Engineering (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662292384P | 2016-02-08 | 2016-02-08 | |
| PCT/US2017/017044 WO2017139398A1 (en) | 2016-02-08 | 2017-02-08 | Compositions and methods for treating chronic wounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2883147T3 true ES2883147T3 (es) | 2021-12-07 |
Family
ID=59563381
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES17750709T Active ES2883147T3 (es) | 2016-02-08 | 2017-02-08 | Composiciones y métodos para el tratamiento de heridas crónicas |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20190046547A1 (enExample) |
| EP (1) | EP3413881B1 (enExample) |
| JP (1) | JP7026050B2 (enExample) |
| AU (1) | AU2017217527A1 (enExample) |
| BR (1) | BR112018016004A2 (enExample) |
| CA (1) | CA3013349A1 (enExample) |
| CL (1) | CL2018002128A1 (enExample) |
| CO (1) | CO2018008856A2 (enExample) |
| ES (1) | ES2883147T3 (enExample) |
| IL (1) | IL261010B (enExample) |
| WO (1) | WO2017139398A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL256312A (en) * | 2017-12-14 | 2018-01-31 | Omrix Biopharmaceuticals Ltd | Antibacterial preparations containing minocycline and oxidized cellulose |
| CN111228561A (zh) * | 2020-01-13 | 2020-06-05 | 张新华 | 一种含中药基质的免涂抹创面敷料 |
| US20240366717A1 (en) * | 2020-08-10 | 2024-11-07 | Gel4Med, Inc. | Antimicrobial matrix formed from peptide hydrogels |
| DE102020134827A1 (de) * | 2020-12-23 | 2022-06-23 | Paul Hartmann Ag | Hydrogel zur Behandlung von Druckgeschwüren |
| CN115040773B (zh) * | 2022-06-22 | 2023-10-13 | 西南交通大学 | 一种治疗慢性感染创面的微针贴片及其制备方法和应用 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4401651A (en) * | 1979-04-18 | 1983-08-30 | Knutson Richard A | Wound-healing compositions containing povidone-iodine |
| JPS6249848A (ja) * | 1985-08-30 | 1987-03-04 | 三金工業株式会社 | 口腔内装着物 |
| US5967979A (en) * | 1995-11-14 | 1999-10-19 | Verg, Inc. | Method and apparatus for photogrammetric assessment of biological tissue |
| DE10031741A1 (de) * | 2000-06-29 | 2002-01-17 | Sanguibio Tech Ag | Einen Sauerstoffträger, ausgewählt aus Hämoglobin oder Hämoglobin- und Myoglobin-enthaltende Zubereitung als Externum zur natürlichen Regeneration der Haut bei Sauerstoff-Mangel |
| CN1272071C (zh) | 2002-03-14 | 2006-08-30 | 美德阿利克斯株式会社 | 创伤用外用剂 |
| JP4922560B2 (ja) * | 2002-12-23 | 2012-04-25 | ウイリアム、マーシュ、ライス、ユーニヴァーサティ | 線維細胞への分化の検出方法、線維症を抑制する組成物および方法 |
| US7731993B2 (en) * | 2004-11-17 | 2010-06-08 | Lindsey Berkson | Composition for treating a dermal anomaly |
| WO2008118370A2 (en) * | 2007-03-22 | 2008-10-02 | The Trustees Of The University Of Pennsylvania | Hyperbaric treatment in wound healing |
| DE102008031183A1 (de) * | 2008-07-03 | 2010-01-07 | Paul Hartmann Ag | Wundauflage |
| EP2226073A1 (en) * | 2009-03-02 | 2010-09-08 | Euro-Celtique S.A. | Topical pharmaceutical composition comprising an antiseptic and arginine for wound healing |
| US20110171284A1 (en) * | 2010-01-11 | 2011-07-14 | Gilman Miles E | Povidone-iodine and sucrose wound healing dressing |
| US20130209592A1 (en) * | 2012-02-13 | 2013-08-15 | Steven C. Denstman | Plant Extract Based Compositions and Methods For Treating Chronic Wounds |
| WO2014150174A1 (en) * | 2013-03-15 | 2014-09-25 | Mccord Darlene E | Methods for improved wound closure employing olivamine and human umbilical vein endothelial cells |
| DE102013018565A1 (de) * | 2013-10-28 | 2015-04-30 | Gmbu E.V., Fachsektion Dresden | Körperpflegemittel und dessen Verwendung |
-
2017
- 2017-02-08 AU AU2017217527A patent/AU2017217527A1/en not_active Abandoned
- 2017-02-08 EP EP17750709.2A patent/EP3413881B1/en active Active
- 2017-02-08 US US16/076,577 patent/US20190046547A1/en active Pending
- 2017-02-08 CA CA3013349A patent/CA3013349A1/en active Pending
- 2017-02-08 BR BR112018016004A patent/BR112018016004A2/pt not_active IP Right Cessation
- 2017-02-08 JP JP2018542712A patent/JP7026050B2/ja active Active
- 2017-02-08 ES ES17750709T patent/ES2883147T3/es active Active
- 2017-02-08 WO PCT/US2017/017044 patent/WO2017139398A1/en not_active Ceased
-
2018
- 2018-08-06 IL IL261010A patent/IL261010B/en unknown
- 2018-08-07 CL CL2018002128A patent/CL2018002128A1/es unknown
- 2018-08-24 CO CONC2018/0008856A patent/CO2018008856A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA3013349A1 (en) | 2017-08-17 |
| EP3413881B1 (en) | 2021-06-30 |
| BR112018016004A2 (pt) | 2018-12-18 |
| EP3413881A1 (en) | 2018-12-19 |
| AU2017217527A1 (en) | 2018-08-23 |
| EP3413881A4 (en) | 2019-09-18 |
| JP2019511468A (ja) | 2019-04-25 |
| IL261010B (en) | 2021-09-30 |
| CO2018008856A2 (es) | 2018-09-10 |
| JP7026050B2 (ja) | 2022-02-25 |
| IL261010A (en) | 2018-10-31 |
| WO2017139398A1 (en) | 2017-08-17 |
| US20190046547A1 (en) | 2019-02-14 |
| CL2018002128A1 (es) | 2019-02-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Baron et al. | Optimal support of wound healing: new insights | |
| Hall et al. | Pathophysiologic mechanisms and current treatments for cutaneous sequelae of burn wounds | |
| Das et al. | Biomaterials and nanotherapeutics for enhancing skin wound healing | |
| RU2705211C2 (ru) | Композиция и способ лечения кожных рубцов | |
| ES2883147T3 (es) | Composiciones y métodos para el tratamiento de heridas crónicas | |
| García-Gareta | Biomaterials for skin repair and regeneration | |
| US20180303970A1 (en) | Compositions and methods for healing wounds | |
| Vachhrajani et al. | Science of wound healing and dressing materials | |
| US11963998B2 (en) | Modulation of heparin-binding epidermal growth factor activity for tympanic membrane healing | |
| JP2018083830A (ja) | 細菌性バイオフィルムを除去するためのセアプローゼの使用 | |
| Han | Innovations and advances in wound healing | |
| ES2467668T3 (es) | Composicón farmaceutica, vendaje y método para tratar lesión cutánea, composición intermedia y proceso para preparar dicho vendaje y uso de sal de cerio asociada con una matriz de colágeno | |
| ES2526640T3 (es) | Composiciones para romper e inhibir la reconstitución de la biopelícula de heridas | |
| JP6087917B2 (ja) | 病理学的瘢痕の予防および治療のためのオリゴサッカライド化合物の使用 | |
| RU2640930C1 (ru) | Способ лечения красного плоского лишая в полости рта | |
| ES2983685T3 (es) | Composición farmacéutica tópica de mupirocina para las infecciones bacterianas y la curación de las heridas | |
| RU2732224C2 (ru) | Раноочищающая композиция для лечения ран | |
| Nayak | A comparative study between collagen and conventional dressing in case of abrasions and second degree burns | |
| KH | Efficacy of Using Topical L-Lysine with Debridement in Chronic Non-Healing Ulcers–A Prospective Study | |
| Copenhagen | 7th Joint Meeting of the European Tissue Repair Society (ETRS) with the Wound Healing Society | |
| Pandey | Comparative Study of Collagenase and Papain–Urea for Ulcer Debridement | |
| Riyaz | A Comparative Study of the Efficacy of Topical Hydrogel Dressings and Conventional Dressings in Chronic Wounds | |
| HK1217166B (en) | Modulation of heparin-binding epidermal growth factor activity for tympanic membrane healing |